Concurrent pharmacological inhibition of PI3Kβ and MLK3 using AZD6482 and URMC-099 exhibited synergistic inhibitory effects on in-vitro GBM cell proliferation, migration and invasion, as well as in-vivo xenograft growth. The gene discussed is MAP3K11; the disease is glioblastoma.